| Borron Family Medicine Pllc | |
|
790 W Ustick Rd Ste 110 Meridian ID 83646-5558 | |
| (208) 639-3990 | |
| (208) 639-3992 |
| Full Name | Borron Family Medicine Pllc |
|---|---|
| Speciality | Nurse Practitioner |
| Location | 790 W Ustick Rd, Meridian, Idaho |
| Authorized Official Name and Position | Brookney Raeanne Borron (OWNER) |
| Authorized Official Contact | 2088661428 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Borron Family Medicine Pllc 790 W Ustick Rd Suite 110 Meridian ID 83646-5558 Ph: (208) 639-3990 | Borron Family Medicine Pllc 790 W Ustick Rd Ste 110 Meridian ID 83646-5558 Ph: (208) 639-3990 |
| NPI Number | 1033424429 |
|---|---|
| Provider Enumeration Date | 08/10/2010 |
| Last Update Date | 02/28/2013 |
| Medicare PECOS PAC ID | 4284889015 |
|---|---|
| Medicare Enrollment ID | O20130228000532 |
News Archive
Gentium S.p.A. has announced top-line results from a historically controlled, multicenter, open label, Phase III trial designed to evaluate the safety and efficacy of 25 mg/kg/day of Defibrotide for the treatment of severe veno-occlusive disease (sVOD) in hematopoietic stem cell transplant (SCT) patients.
SweetSpot Diabetes Care, Inc. has registered their Diabetes Device Data Transfer service as a Medical Device Data System (MDDS) with the FDA the Company announced today, while attending the 71st Annual American Diabetes Association Scientific Sessions meeting in San Diego, CA.
A group of scientists from The Scripps Research Institute and several other institutions has solved the structure of a rare human antibody that broadly neutralizes human immunodeficiency virus (HIV), which causes acquired immunodeficiency syndrome (AIDS).
Rockwell Medical, a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease, chronic kidney disease, and iron deficiency anemia, announced today that it has successfully completed an End of Phase II meeting with the U.S. Food and Drug Administration regarding the Company's lead drug candidate Soluble Ferric Pyrophosphate, a novel continuous iron-replacement therapy designed to treat iron deficiency anemia in hemodialysis patients.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033424429 | NPI | - | NPPES |
| 1033424429 | Medicaid | ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QP2300X | Clinic/center - Primary Care | (* (Not Available)) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | NP-923A (Idaho) | Primary |
| Provider Name | Brookney R Stone |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1053543660 PECOS PAC ID: 1456407949 Enrollment ID: I20090924000688 |
News Archive
Gentium S.p.A. has announced top-line results from a historically controlled, multicenter, open label, Phase III trial designed to evaluate the safety and efficacy of 25 mg/kg/day of Defibrotide for the treatment of severe veno-occlusive disease (sVOD) in hematopoietic stem cell transplant (SCT) patients.
SweetSpot Diabetes Care, Inc. has registered their Diabetes Device Data Transfer service as a Medical Device Data System (MDDS) with the FDA the Company announced today, while attending the 71st Annual American Diabetes Association Scientific Sessions meeting in San Diego, CA.
A group of scientists from The Scripps Research Institute and several other institutions has solved the structure of a rare human antibody that broadly neutralizes human immunodeficiency virus (HIV), which causes acquired immunodeficiency syndrome (AIDS).
Rockwell Medical, a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease, chronic kidney disease, and iron deficiency anemia, announced today that it has successfully completed an End of Phase II meeting with the U.S. Food and Drug Administration regarding the Company's lead drug candidate Soluble Ferric Pyrophosphate, a novel continuous iron-replacement therapy designed to treat iron deficiency anemia in hemodialysis patients.
› Verified 7 days ago
| Provider Name | Christie Beattie |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1164734240 PECOS PAC ID: 0749426765 Enrollment ID: I20130418000133 |
News Archive
Gentium S.p.A. has announced top-line results from a historically controlled, multicenter, open label, Phase III trial designed to evaluate the safety and efficacy of 25 mg/kg/day of Defibrotide for the treatment of severe veno-occlusive disease (sVOD) in hematopoietic stem cell transplant (SCT) patients.
SweetSpot Diabetes Care, Inc. has registered their Diabetes Device Data Transfer service as a Medical Device Data System (MDDS) with the FDA the Company announced today, while attending the 71st Annual American Diabetes Association Scientific Sessions meeting in San Diego, CA.
A group of scientists from The Scripps Research Institute and several other institutions has solved the structure of a rare human antibody that broadly neutralizes human immunodeficiency virus (HIV), which causes acquired immunodeficiency syndrome (AIDS).
Rockwell Medical, a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease, chronic kidney disease, and iron deficiency anemia, announced today that it has successfully completed an End of Phase II meeting with the U.S. Food and Drug Administration regarding the Company's lead drug candidate Soluble Ferric Pyrophosphate, a novel continuous iron-replacement therapy designed to treat iron deficiency anemia in hemodialysis patients.
› Verified 7 days ago
| Provider Name | Whitney L Finch |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1144728718 PECOS PAC ID: 9830451012 Enrollment ID: I20210125003025 |
News Archive
Gentium S.p.A. has announced top-line results from a historically controlled, multicenter, open label, Phase III trial designed to evaluate the safety and efficacy of 25 mg/kg/day of Defibrotide for the treatment of severe veno-occlusive disease (sVOD) in hematopoietic stem cell transplant (SCT) patients.
SweetSpot Diabetes Care, Inc. has registered their Diabetes Device Data Transfer service as a Medical Device Data System (MDDS) with the FDA the Company announced today, while attending the 71st Annual American Diabetes Association Scientific Sessions meeting in San Diego, CA.
A group of scientists from The Scripps Research Institute and several other institutions has solved the structure of a rare human antibody that broadly neutralizes human immunodeficiency virus (HIV), which causes acquired immunodeficiency syndrome (AIDS).
Rockwell Medical, a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease, chronic kidney disease, and iron deficiency anemia, announced today that it has successfully completed an End of Phase II meeting with the U.S. Food and Drug Administration regarding the Company's lead drug candidate Soluble Ferric Pyrophosphate, a novel continuous iron-replacement therapy designed to treat iron deficiency anemia in hemodialysis patients.
› Verified 7 days ago
News Archive
Gentium S.p.A. has announced top-line results from a historically controlled, multicenter, open label, Phase III trial designed to evaluate the safety and efficacy of 25 mg/kg/day of Defibrotide for the treatment of severe veno-occlusive disease (sVOD) in hematopoietic stem cell transplant (SCT) patients.
SweetSpot Diabetes Care, Inc. has registered their Diabetes Device Data Transfer service as a Medical Device Data System (MDDS) with the FDA the Company announced today, while attending the 71st Annual American Diabetes Association Scientific Sessions meeting in San Diego, CA.
A group of scientists from The Scripps Research Institute and several other institutions has solved the structure of a rare human antibody that broadly neutralizes human immunodeficiency virus (HIV), which causes acquired immunodeficiency syndrome (AIDS).
Rockwell Medical, a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease, chronic kidney disease, and iron deficiency anemia, announced today that it has successfully completed an End of Phase II meeting with the U.S. Food and Drug Administration regarding the Company's lead drug candidate Soluble Ferric Pyrophosphate, a novel continuous iron-replacement therapy designed to treat iron deficiency anemia in hemodialysis patients.
› Verified 7 days ago
Jared M Furgeson Dds Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2700 W Cherry Ln, Suite 120, Meridian, ID 83642 Phone: 208-887-9000 | |
Hampton Roads Medical Specialists Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2131 S Bonito Way, Meridian, ID 83642 Phone: 208-489-9500 | |
Vast Durable Medical Equipment Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2985 S Meridian Rd Ste 140, Meridian, ID 83642 Phone: 208-860-2849 | |
Primary Health Medical Group Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1623 South Wells Avenue, Meridian, ID 83642 Phone: 208-489-1450 Fax: 208-489-1451 | |
Virtare Health Physician Services Of Idaho, Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3597 E Monarch Sky Ln Ste 240, Meridian, ID 83646 Phone: 855-745-8400 | |
Terry Reilly Health Services Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3115 E Florence Dr, Meridian, ID 83642 Phone: 208-932-8992 Fax: 208-370-6215 |